Hyzetimibe is a cholesterol absorption inhibitor. Hyzetimibe blocks the intestinal absorption of cholesterol and phytol. Hyzetimibe is well tolerated in animal models, with an LD max 2000 mg/kg in rats and an LD max 500 mg/kg in rhesus monkeys.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Research Areas > Metabolic Disease
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye